Global Next Generation Sequencing (NGS) Solution Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Next Generation Sequencing (NGS) Solution market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Next Generation Sequencing (NGS) Solution market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Next Generation Sequencing (NGS) Solution market size and forecasts, in consumption value ($ Million), 2018-2029
Global Next Generation Sequencing (NGS) Solution market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Next Generation Sequencing (NGS) Solution market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Next Generation Sequencing (NGS) Solution market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next Generation Sequencing (NGS) Solution
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next Generation Sequencing (NGS) Solution market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding and Agilent Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Next Generation Sequencing (NGS) Solution market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Next Generation Sequencing (NGS) Solution product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next Generation Sequencing (NGS) Solution, with revenue, gross margin and global market share of Next Generation Sequencing (NGS) Solution from 2018 to 2023.
Chapter 3, the Next Generation Sequencing (NGS) Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Next Generation Sequencing (NGS) Solution market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Next Generation Sequencing (NGS) Solution.
Chapter 13, to describe Next Generation Sequencing (NGS) Solution research findings and conclusion.
This report is a detailed and comprehensive analysis for global Next Generation Sequencing (NGS) Solution market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Next Generation Sequencing (NGS) Solution market size and forecasts, in consumption value ($ Million), 2018-2029
Global Next Generation Sequencing (NGS) Solution market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Next Generation Sequencing (NGS) Solution market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Next Generation Sequencing (NGS) Solution market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next Generation Sequencing (NGS) Solution
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next Generation Sequencing (NGS) Solution market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding and Agilent Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Next Generation Sequencing (NGS) Solution market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Whole Genome Sequencing
- Whole Exome Sequencing
- Targeted Sequencing and Resequencing Centrifuges
- Sporadic Cancer
- Inherited Cancer
- Companion Diagnostics
- Others
- Illumina
- PerkinElmer
- Thermo Fisher Scientific
- Roche Holding
- Agilent Technologies
- Myriad Genetics
- Foundation Medicine
- Oxford Nanopore Technologies
- Pacific Biosciences
- Paradigm Diagnostics
- BGI Group
- Caris Life Sciences
- Partek
- Eurofins Scientific
- Qiagen
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Next Generation Sequencing (NGS) Solution product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next Generation Sequencing (NGS) Solution, with revenue, gross margin and global market share of Next Generation Sequencing (NGS) Solution from 2018 to 2023.
Chapter 3, the Next Generation Sequencing (NGS) Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Next Generation Sequencing (NGS) Solution market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Next Generation Sequencing (NGS) Solution.
Chapter 13, to describe Next Generation Sequencing (NGS) Solution research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Next Generation Sequencing (NGS) Solution
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next Generation Sequencing (NGS) Solution by Type
1.3.1 Overview: Global Next Generation Sequencing (NGS) Solution Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type in 2022
1.3.3 Whole Genome Sequencing
1.3.4 Whole Exome Sequencing
1.3.5 Targeted Sequencing and Resequencing Centrifuges
1.4 Global Next Generation Sequencing (NGS) Solution Market by Application
1.4.1 Overview: Global Next Generation Sequencing (NGS) Solution Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Sporadic Cancer
1.4.3 Inherited Cancer
1.4.4 Companion Diagnostics
1.4.5 Others
1.5 Global Next Generation Sequencing (NGS) Solution Market Size & Forecast
1.6 Global Next Generation Sequencing (NGS) Solution Market Size and Forecast by Region
1.6.1 Global Next Generation Sequencing (NGS) Solution Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Next Generation Sequencing (NGS) Solution Market Size by Region, (2018-2029)
1.6.3 North America Next Generation Sequencing (NGS) Solution Market Size and Prospect (2018-2029)
1.6.4 Europe Next Generation Sequencing (NGS) Solution Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size and Prospect (2018-2029)
1.6.6 South America Next Generation Sequencing (NGS) Solution Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina Next Generation Sequencing (NGS) Solution Product and Solutions
2.1.4 Illumina Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Illumina Recent Developments and Future Plans
2.2 PerkinElmer
2.2.1 PerkinElmer Details
2.2.2 PerkinElmer Major Business
2.2.3 PerkinElmer Next Generation Sequencing (NGS) Solution Product and Solutions
2.2.4 PerkinElmer Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 PerkinElmer Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product and Solutions
2.3.4 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Roche Holding
2.4.1 Roche Holding Details
2.4.2 Roche Holding Major Business
2.4.3 Roche Holding Next Generation Sequencing (NGS) Solution Product and Solutions
2.4.4 Roche Holding Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Roche Holding Recent Developments and Future Plans
2.5 Agilent Technologies
2.5.1 Agilent Technologies Details
2.5.2 Agilent Technologies Major Business
2.5.3 Agilent Technologies Next Generation Sequencing (NGS) Solution Product and Solutions
2.5.4 Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Agilent Technologies Recent Developments and Future Plans
2.6 Myriad Genetics
2.6.1 Myriad Genetics Details
2.6.2 Myriad Genetics Major Business
2.6.3 Myriad Genetics Next Generation Sequencing (NGS) Solution Product and Solutions
2.6.4 Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Myriad Genetics Recent Developments and Future Plans
2.7 Foundation Medicine
2.7.1 Foundation Medicine Details
2.7.2 Foundation Medicine Major Business
2.7.3 Foundation Medicine Next Generation Sequencing (NGS) Solution Product and Solutions
2.7.4 Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Foundation Medicine Recent Developments and Future Plans
2.8 Oxford Nanopore Technologies
2.8.1 Oxford Nanopore Technologies Details
2.8.2 Oxford Nanopore Technologies Major Business
2.8.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product and Solutions
2.8.4 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Oxford Nanopore Technologies Recent Developments and Future Plans
2.9 Pacific Biosciences
2.9.1 Pacific Biosciences Details
2.9.2 Pacific Biosciences Major Business
2.9.3 Pacific Biosciences Next Generation Sequencing (NGS) Solution Product and Solutions
2.9.4 Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pacific Biosciences Recent Developments and Future Plans
2.10 Paradigm Diagnostics
2.10.1 Paradigm Diagnostics Details
2.10.2 Paradigm Diagnostics Major Business
2.10.3 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product and Solutions
2.10.4 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Paradigm Diagnostics Recent Developments and Future Plans
2.11 BGI Group
2.11.1 BGI Group Details
2.11.2 BGI Group Major Business
2.11.3 BGI Group Next Generation Sequencing (NGS) Solution Product and Solutions
2.11.4 BGI Group Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BGI Group Recent Developments and Future Plans
2.12 Caris Life Sciences
2.12.1 Caris Life Sciences Details
2.12.2 Caris Life Sciences Major Business
2.12.3 Caris Life Sciences Next Generation Sequencing (NGS) Solution Product and Solutions
2.12.4 Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Caris Life Sciences Recent Developments and Future Plans
2.13 Partek
2.13.1 Partek Details
2.13.2 Partek Major Business
2.13.3 Partek Next Generation Sequencing (NGS) Solution Product and Solutions
2.13.4 Partek Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Partek Recent Developments and Future Plans
2.14 Eurofins Scientific
2.14.1 Eurofins Scientific Details
2.14.2 Eurofins Scientific Major Business
2.14.3 Eurofins Scientific Next Generation Sequencing (NGS) Solution Product and Solutions
2.14.4 Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Eurofins Scientific Recent Developments and Future Plans
2.15 Qiagen
2.15.1 Qiagen Details
2.15.2 Qiagen Major Business
2.15.3 Qiagen Next Generation Sequencing (NGS) Solution Product and Solutions
2.15.4 Qiagen Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Qiagen Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Next Generation Sequencing (NGS) Solution Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Next Generation Sequencing (NGS) Solution by Company Revenue
3.2.2 Top 3 Next Generation Sequencing (NGS) Solution Players Market Share in 2022
3.2.3 Top 6 Next Generation Sequencing (NGS) Solution Players Market Share in 2022
3.3 Next Generation Sequencing (NGS) Solution Market: Overall Company Footprint Analysis
3.3.1 Next Generation Sequencing (NGS) Solution Market: Region Footprint
3.3.2 Next Generation Sequencing (NGS) Solution Market: Company Product Type Footprint
3.3.3 Next Generation Sequencing (NGS) Solution Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Next Generation Sequencing (NGS) Solution Consumption Value and Market Share by Type (2018-2023)
4.2 Global Next Generation Sequencing (NGS) Solution Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2023)
5.2 Global Next Generation Sequencing (NGS) Solution Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2029)
6.2 North America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2029)
6.3 North America Next Generation Sequencing (NGS) Solution Market Size by Country
6.3.1 North America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2029)
6.3.2 United States Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
6.3.3 Canada Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
6.3.4 Mexico Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2029)
7.2 Europe Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2029)
7.3 Europe Next Generation Sequencing (NGS) Solution Market Size by Country
7.3.1 Europe Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2029)
7.3.2 Germany Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
7.3.3 France Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
7.3.5 Russia Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
7.3.6 Italy Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Region
8.3.1 Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Region (2018-2029)
8.3.2 China Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8.3.3 Japan Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8.3.4 South Korea Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8.3.5 India Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8.3.7 Australia Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2029)
9.2 South America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2029)
9.3 South America Next Generation Sequencing (NGS) Solution Market Size by Country
9.3.1 South America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2029)
9.3.2 Brazil Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
9.3.3 Argentina Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Country
10.3.1 Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2029)
10.3.2 Turkey Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
10.3.4 UAE Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Next Generation Sequencing (NGS) Solution Market Drivers
11.2 Next Generation Sequencing (NGS) Solution Market Restraints
11.3 Next Generation Sequencing (NGS) Solution Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Next Generation Sequencing (NGS) Solution Industry Chain
12.2 Next Generation Sequencing (NGS) Solution Upstream Analysis
12.3 Next Generation Sequencing (NGS) Solution Midstream Analysis
12.4 Next Generation Sequencing (NGS) Solution Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Next Generation Sequencing (NGS) Solution
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next Generation Sequencing (NGS) Solution by Type
1.3.1 Overview: Global Next Generation Sequencing (NGS) Solution Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type in 2022
1.3.3 Whole Genome Sequencing
1.3.4 Whole Exome Sequencing
1.3.5 Targeted Sequencing and Resequencing Centrifuges
1.4 Global Next Generation Sequencing (NGS) Solution Market by Application
1.4.1 Overview: Global Next Generation Sequencing (NGS) Solution Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Sporadic Cancer
1.4.3 Inherited Cancer
1.4.4 Companion Diagnostics
1.4.5 Others
1.5 Global Next Generation Sequencing (NGS) Solution Market Size & Forecast
1.6 Global Next Generation Sequencing (NGS) Solution Market Size and Forecast by Region
1.6.1 Global Next Generation Sequencing (NGS) Solution Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Next Generation Sequencing (NGS) Solution Market Size by Region, (2018-2029)
1.6.3 North America Next Generation Sequencing (NGS) Solution Market Size and Prospect (2018-2029)
1.6.4 Europe Next Generation Sequencing (NGS) Solution Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size and Prospect (2018-2029)
1.6.6 South America Next Generation Sequencing (NGS) Solution Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina Next Generation Sequencing (NGS) Solution Product and Solutions
2.1.4 Illumina Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Illumina Recent Developments and Future Plans
2.2 PerkinElmer
2.2.1 PerkinElmer Details
2.2.2 PerkinElmer Major Business
2.2.3 PerkinElmer Next Generation Sequencing (NGS) Solution Product and Solutions
2.2.4 PerkinElmer Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 PerkinElmer Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product and Solutions
2.3.4 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Roche Holding
2.4.1 Roche Holding Details
2.4.2 Roche Holding Major Business
2.4.3 Roche Holding Next Generation Sequencing (NGS) Solution Product and Solutions
2.4.4 Roche Holding Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Roche Holding Recent Developments and Future Plans
2.5 Agilent Technologies
2.5.1 Agilent Technologies Details
2.5.2 Agilent Technologies Major Business
2.5.3 Agilent Technologies Next Generation Sequencing (NGS) Solution Product and Solutions
2.5.4 Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Agilent Technologies Recent Developments and Future Plans
2.6 Myriad Genetics
2.6.1 Myriad Genetics Details
2.6.2 Myriad Genetics Major Business
2.6.3 Myriad Genetics Next Generation Sequencing (NGS) Solution Product and Solutions
2.6.4 Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Myriad Genetics Recent Developments and Future Plans
2.7 Foundation Medicine
2.7.1 Foundation Medicine Details
2.7.2 Foundation Medicine Major Business
2.7.3 Foundation Medicine Next Generation Sequencing (NGS) Solution Product and Solutions
2.7.4 Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Foundation Medicine Recent Developments and Future Plans
2.8 Oxford Nanopore Technologies
2.8.1 Oxford Nanopore Technologies Details
2.8.2 Oxford Nanopore Technologies Major Business
2.8.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product and Solutions
2.8.4 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Oxford Nanopore Technologies Recent Developments and Future Plans
2.9 Pacific Biosciences
2.9.1 Pacific Biosciences Details
2.9.2 Pacific Biosciences Major Business
2.9.3 Pacific Biosciences Next Generation Sequencing (NGS) Solution Product and Solutions
2.9.4 Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pacific Biosciences Recent Developments and Future Plans
2.10 Paradigm Diagnostics
2.10.1 Paradigm Diagnostics Details
2.10.2 Paradigm Diagnostics Major Business
2.10.3 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product and Solutions
2.10.4 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Paradigm Diagnostics Recent Developments and Future Plans
2.11 BGI Group
2.11.1 BGI Group Details
2.11.2 BGI Group Major Business
2.11.3 BGI Group Next Generation Sequencing (NGS) Solution Product and Solutions
2.11.4 BGI Group Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BGI Group Recent Developments and Future Plans
2.12 Caris Life Sciences
2.12.1 Caris Life Sciences Details
2.12.2 Caris Life Sciences Major Business
2.12.3 Caris Life Sciences Next Generation Sequencing (NGS) Solution Product and Solutions
2.12.4 Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Caris Life Sciences Recent Developments and Future Plans
2.13 Partek
2.13.1 Partek Details
2.13.2 Partek Major Business
2.13.3 Partek Next Generation Sequencing (NGS) Solution Product and Solutions
2.13.4 Partek Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Partek Recent Developments and Future Plans
2.14 Eurofins Scientific
2.14.1 Eurofins Scientific Details
2.14.2 Eurofins Scientific Major Business
2.14.3 Eurofins Scientific Next Generation Sequencing (NGS) Solution Product and Solutions
2.14.4 Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Eurofins Scientific Recent Developments and Future Plans
2.15 Qiagen
2.15.1 Qiagen Details
2.15.2 Qiagen Major Business
2.15.3 Qiagen Next Generation Sequencing (NGS) Solution Product and Solutions
2.15.4 Qiagen Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Qiagen Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Next Generation Sequencing (NGS) Solution Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Next Generation Sequencing (NGS) Solution by Company Revenue
3.2.2 Top 3 Next Generation Sequencing (NGS) Solution Players Market Share in 2022
3.2.3 Top 6 Next Generation Sequencing (NGS) Solution Players Market Share in 2022
3.3 Next Generation Sequencing (NGS) Solution Market: Overall Company Footprint Analysis
3.3.1 Next Generation Sequencing (NGS) Solution Market: Region Footprint
3.3.2 Next Generation Sequencing (NGS) Solution Market: Company Product Type Footprint
3.3.3 Next Generation Sequencing (NGS) Solution Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Next Generation Sequencing (NGS) Solution Consumption Value and Market Share by Type (2018-2023)
4.2 Global Next Generation Sequencing (NGS) Solution Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2023)
5.2 Global Next Generation Sequencing (NGS) Solution Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2029)
6.2 North America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2029)
6.3 North America Next Generation Sequencing (NGS) Solution Market Size by Country
6.3.1 North America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2029)
6.3.2 United States Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
6.3.3 Canada Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
6.3.4 Mexico Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2029)
7.2 Europe Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2029)
7.3 Europe Next Generation Sequencing (NGS) Solution Market Size by Country
7.3.1 Europe Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2029)
7.3.2 Germany Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
7.3.3 France Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
7.3.5 Russia Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
7.3.6 Italy Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Region
8.3.1 Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Region (2018-2029)
8.3.2 China Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8.3.3 Japan Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8.3.4 South Korea Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8.3.5 India Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
8.3.7 Australia Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2029)
9.2 South America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2029)
9.3 South America Next Generation Sequencing (NGS) Solution Market Size by Country
9.3.1 South America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2029)
9.3.2 Brazil Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
9.3.3 Argentina Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Next Generation Sequencing (NGS) Solution Market Size by Country
10.3.1 Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2029)
10.3.2 Turkey Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
10.3.4 UAE Next Generation Sequencing (NGS) Solution Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Next Generation Sequencing (NGS) Solution Market Drivers
11.2 Next Generation Sequencing (NGS) Solution Market Restraints
11.3 Next Generation Sequencing (NGS) Solution Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Next Generation Sequencing (NGS) Solution Industry Chain
12.2 Next Generation Sequencing (NGS) Solution Upstream Analysis
12.3 Next Generation Sequencing (NGS) Solution Midstream Analysis
12.4 Next Generation Sequencing (NGS) Solution Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Next Generation Sequencing (NGS) Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Next Generation Sequencing (NGS) Solution Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Next Generation Sequencing (NGS) Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Next Generation Sequencing (NGS) Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Illumina Company Information, Head Office, and Major Competitors
Table 6. Illumina Major Business
Table 7. Illumina Next Generation Sequencing (NGS) Solution Product and Solutions
Table 8. Illumina Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Illumina Recent Developments and Future Plans
Table 10. PerkinElmer Company Information, Head Office, and Major Competitors
Table 11. PerkinElmer Major Business
Table 12. PerkinElmer Next Generation Sequencing (NGS) Solution Product and Solutions
Table 13. PerkinElmer Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. PerkinElmer Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product and Solutions
Table 18. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. Roche Holding Company Information, Head Office, and Major Competitors
Table 21. Roche Holding Major Business
Table 22. Roche Holding Next Generation Sequencing (NGS) Solution Product and Solutions
Table 23. Roche Holding Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Roche Holding Recent Developments and Future Plans
Table 25. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 26. Agilent Technologies Major Business
Table 27. Agilent Technologies Next Generation Sequencing (NGS) Solution Product and Solutions
Table 28. Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Agilent Technologies Recent Developments and Future Plans
Table 30. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 31. Myriad Genetics Major Business
Table 32. Myriad Genetics Next Generation Sequencing (NGS) Solution Product and Solutions
Table 33. Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Myriad Genetics Recent Developments and Future Plans
Table 35. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 36. Foundation Medicine Major Business
Table 37. Foundation Medicine Next Generation Sequencing (NGS) Solution Product and Solutions
Table 38. Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Foundation Medicine Recent Developments and Future Plans
Table 40. Oxford Nanopore Technologies Company Information, Head Office, and Major Competitors
Table 41. Oxford Nanopore Technologies Major Business
Table 42. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product and Solutions
Table 43. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Oxford Nanopore Technologies Recent Developments and Future Plans
Table 45. Pacific Biosciences Company Information, Head Office, and Major Competitors
Table 46. Pacific Biosciences Major Business
Table 47. Pacific Biosciences Next Generation Sequencing (NGS) Solution Product and Solutions
Table 48. Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Pacific Biosciences Recent Developments and Future Plans
Table 50. Paradigm Diagnostics Company Information, Head Office, and Major Competitors
Table 51. Paradigm Diagnostics Major Business
Table 52. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product and Solutions
Table 53. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Paradigm Diagnostics Recent Developments and Future Plans
Table 55. BGI Group Company Information, Head Office, and Major Competitors
Table 56. BGI Group Major Business
Table 57. BGI Group Next Generation Sequencing (NGS) Solution Product and Solutions
Table 58. BGI Group Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BGI Group Recent Developments and Future Plans
Table 60. Caris Life Sciences Company Information, Head Office, and Major Competitors
Table 61. Caris Life Sciences Major Business
Table 62. Caris Life Sciences Next Generation Sequencing (NGS) Solution Product and Solutions
Table 63. Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Caris Life Sciences Recent Developments and Future Plans
Table 65. Partek Company Information, Head Office, and Major Competitors
Table 66. Partek Major Business
Table 67. Partek Next Generation Sequencing (NGS) Solution Product and Solutions
Table 68. Partek Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Partek Recent Developments and Future Plans
Table 70. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 71. Eurofins Scientific Major Business
Table 72. Eurofins Scientific Next Generation Sequencing (NGS) Solution Product and Solutions
Table 73. Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Eurofins Scientific Recent Developments and Future Plans
Table 75. Qiagen Company Information, Head Office, and Major Competitors
Table 76. Qiagen Major Business
Table 77. Qiagen Next Generation Sequencing (NGS) Solution Product and Solutions
Table 78. Qiagen Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Qiagen Recent Developments and Future Plans
Table 80. Global Next Generation Sequencing (NGS) Solution Revenue (USD Million) by Players (2018-2023)
Table 81. Global Next Generation Sequencing (NGS) Solution Revenue Share by Players (2018-2023)
Table 82. Breakdown of Next Generation Sequencing (NGS) Solution by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Next Generation Sequencing (NGS) Solution, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Next Generation Sequencing (NGS) Solution Players
Table 85. Next Generation Sequencing (NGS) Solution Market: Company Product Type Footprint
Table 86. Next Generation Sequencing (NGS) Solution Market: Company Product Application Footprint
Table 87. Next Generation Sequencing (NGS) Solution New Market Entrants and Barriers to Market Entry
Table 88. Next Generation Sequencing (NGS) Solution Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Next Generation Sequencing (NGS) Solution Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Next Generation Sequencing (NGS) Solution Consumption Value Share by Type (2018-2023)
Table 91. Global Next Generation Sequencing (NGS) Solution Consumption Value Forecast by Type (2024-2029)
Table 92. Global Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023)
Table 93. Global Next Generation Sequencing (NGS) Solution Consumption Value Forecast by Application (2024-2029)
Table 94. North America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Next Generation Sequencing (NGS) Solution Raw Material
Table 125. Key Suppliers of Next Generation Sequencing (NGS) Solution Raw Materials
Table 1. Global Next Generation Sequencing (NGS) Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Next Generation Sequencing (NGS) Solution Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Next Generation Sequencing (NGS) Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Next Generation Sequencing (NGS) Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Illumina Company Information, Head Office, and Major Competitors
Table 6. Illumina Major Business
Table 7. Illumina Next Generation Sequencing (NGS) Solution Product and Solutions
Table 8. Illumina Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Illumina Recent Developments and Future Plans
Table 10. PerkinElmer Company Information, Head Office, and Major Competitors
Table 11. PerkinElmer Major Business
Table 12. PerkinElmer Next Generation Sequencing (NGS) Solution Product and Solutions
Table 13. PerkinElmer Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. PerkinElmer Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product and Solutions
Table 18. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. Roche Holding Company Information, Head Office, and Major Competitors
Table 21. Roche Holding Major Business
Table 22. Roche Holding Next Generation Sequencing (NGS) Solution Product and Solutions
Table 23. Roche Holding Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Roche Holding Recent Developments and Future Plans
Table 25. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 26. Agilent Technologies Major Business
Table 27. Agilent Technologies Next Generation Sequencing (NGS) Solution Product and Solutions
Table 28. Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Agilent Technologies Recent Developments and Future Plans
Table 30. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 31. Myriad Genetics Major Business
Table 32. Myriad Genetics Next Generation Sequencing (NGS) Solution Product and Solutions
Table 33. Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Myriad Genetics Recent Developments and Future Plans
Table 35. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 36. Foundation Medicine Major Business
Table 37. Foundation Medicine Next Generation Sequencing (NGS) Solution Product and Solutions
Table 38. Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Foundation Medicine Recent Developments and Future Plans
Table 40. Oxford Nanopore Technologies Company Information, Head Office, and Major Competitors
Table 41. Oxford Nanopore Technologies Major Business
Table 42. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product and Solutions
Table 43. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Oxford Nanopore Technologies Recent Developments and Future Plans
Table 45. Pacific Biosciences Company Information, Head Office, and Major Competitors
Table 46. Pacific Biosciences Major Business
Table 47. Pacific Biosciences Next Generation Sequencing (NGS) Solution Product and Solutions
Table 48. Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Pacific Biosciences Recent Developments and Future Plans
Table 50. Paradigm Diagnostics Company Information, Head Office, and Major Competitors
Table 51. Paradigm Diagnostics Major Business
Table 52. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product and Solutions
Table 53. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Paradigm Diagnostics Recent Developments and Future Plans
Table 55. BGI Group Company Information, Head Office, and Major Competitors
Table 56. BGI Group Major Business
Table 57. BGI Group Next Generation Sequencing (NGS) Solution Product and Solutions
Table 58. BGI Group Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BGI Group Recent Developments and Future Plans
Table 60. Caris Life Sciences Company Information, Head Office, and Major Competitors
Table 61. Caris Life Sciences Major Business
Table 62. Caris Life Sciences Next Generation Sequencing (NGS) Solution Product and Solutions
Table 63. Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Caris Life Sciences Recent Developments and Future Plans
Table 65. Partek Company Information, Head Office, and Major Competitors
Table 66. Partek Major Business
Table 67. Partek Next Generation Sequencing (NGS) Solution Product and Solutions
Table 68. Partek Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Partek Recent Developments and Future Plans
Table 70. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 71. Eurofins Scientific Major Business
Table 72. Eurofins Scientific Next Generation Sequencing (NGS) Solution Product and Solutions
Table 73. Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Eurofins Scientific Recent Developments and Future Plans
Table 75. Qiagen Company Information, Head Office, and Major Competitors
Table 76. Qiagen Major Business
Table 77. Qiagen Next Generation Sequencing (NGS) Solution Product and Solutions
Table 78. Qiagen Next Generation Sequencing (NGS) Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Qiagen Recent Developments and Future Plans
Table 80. Global Next Generation Sequencing (NGS) Solution Revenue (USD Million) by Players (2018-2023)
Table 81. Global Next Generation Sequencing (NGS) Solution Revenue Share by Players (2018-2023)
Table 82. Breakdown of Next Generation Sequencing (NGS) Solution by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Next Generation Sequencing (NGS) Solution, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Next Generation Sequencing (NGS) Solution Players
Table 85. Next Generation Sequencing (NGS) Solution Market: Company Product Type Footprint
Table 86. Next Generation Sequencing (NGS) Solution Market: Company Product Application Footprint
Table 87. Next Generation Sequencing (NGS) Solution New Market Entrants and Barriers to Market Entry
Table 88. Next Generation Sequencing (NGS) Solution Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Next Generation Sequencing (NGS) Solution Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Next Generation Sequencing (NGS) Solution Consumption Value Share by Type (2018-2023)
Table 91. Global Next Generation Sequencing (NGS) Solution Consumption Value Forecast by Type (2024-2029)
Table 92. Global Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023)
Table 93. Global Next Generation Sequencing (NGS) Solution Consumption Value Forecast by Application (2024-2029)
Table 94. North America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Next Generation Sequencing (NGS) Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Next Generation Sequencing (NGS) Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Next Generation Sequencing (NGS) Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Next Generation Sequencing (NGS) Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Next Generation Sequencing (NGS) Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Next Generation Sequencing (NGS) Solution Raw Material
Table 125. Key Suppliers of Next Generation Sequencing (NGS) Solution Raw Materials
LIST OF FIGURES
Figure 1. Next Generation Sequencing (NGS) Solution Picture
Figure 2. Global Next Generation Sequencing (NGS) Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type in 2022
Figure 4. Whole Genome Sequencing
Figure 5. Whole Exome Sequencing
Figure 6. Targeted Sequencing and Resequencing Centrifuges
Figure 7. Global Next Generation Sequencing (NGS) Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application in 2022
Figure 9. Sporadic Cancer Picture
Figure 10. Inherited Cancer Picture
Figure 11. Companion Diagnostics Picture
Figure 12. Others Picture
Figure 13. Global Next Generation Sequencing (NGS) Solution Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Next Generation Sequencing (NGS) Solution Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Next Generation Sequencing (NGS) Solution Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Region in 2022
Figure 18. North America Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Next Generation Sequencing (NGS) Solution Revenue Share by Players in 2022
Figure 24. Next Generation Sequencing (NGS) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Next Generation Sequencing (NGS) Solution Market Share in 2022
Figure 26. Global Top 6 Players Next Generation Sequencing (NGS) Solution Market Share in 2022
Figure 27. Global Next Generation Sequencing (NGS) Solution Consumption Value Share by Type (2018-2023)
Figure 28. Global Next Generation Sequencing (NGS) Solution Market Share Forecast by Type (2024-2029)
Figure 29. Global Next Generation Sequencing (NGS) Solution Consumption Value Share by Application (2018-2023)
Figure 30. Global Next Generation Sequencing (NGS) Solution Market Share Forecast by Application (2024-2029)
Figure 31. North America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 41. France Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Region (2018-2029)
Figure 48. China Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 51. India Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 65. Next Generation Sequencing (NGS) Solution Market Drivers
Figure 66. Next Generation Sequencing (NGS) Solution Market Restraints
Figure 67. Next Generation Sequencing (NGS) Solution Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Next Generation Sequencing (NGS) Solution in 2022
Figure 70. Manufacturing Process Analysis of Next Generation Sequencing (NGS) Solution
Figure 71. Next Generation Sequencing (NGS) Solution Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Next Generation Sequencing (NGS) Solution Picture
Figure 2. Global Next Generation Sequencing (NGS) Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type in 2022
Figure 4. Whole Genome Sequencing
Figure 5. Whole Exome Sequencing
Figure 6. Targeted Sequencing and Resequencing Centrifuges
Figure 7. Global Next Generation Sequencing (NGS) Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application in 2022
Figure 9. Sporadic Cancer Picture
Figure 10. Inherited Cancer Picture
Figure 11. Companion Diagnostics Picture
Figure 12. Others Picture
Figure 13. Global Next Generation Sequencing (NGS) Solution Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Next Generation Sequencing (NGS) Solution Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Next Generation Sequencing (NGS) Solution Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Region in 2022
Figure 18. North America Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Next Generation Sequencing (NGS) Solution Revenue Share by Players in 2022
Figure 24. Next Generation Sequencing (NGS) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Next Generation Sequencing (NGS) Solution Market Share in 2022
Figure 26. Global Top 6 Players Next Generation Sequencing (NGS) Solution Market Share in 2022
Figure 27. Global Next Generation Sequencing (NGS) Solution Consumption Value Share by Type (2018-2023)
Figure 28. Global Next Generation Sequencing (NGS) Solution Market Share Forecast by Type (2024-2029)
Figure 29. Global Next Generation Sequencing (NGS) Solution Consumption Value Share by Application (2018-2023)
Figure 30. Global Next Generation Sequencing (NGS) Solution Market Share Forecast by Application (2024-2029)
Figure 31. North America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 41. France Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Region (2018-2029)
Figure 48. China Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 51. India Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 65. Next Generation Sequencing (NGS) Solution Market Drivers
Figure 66. Next Generation Sequencing (NGS) Solution Market Restraints
Figure 67. Next Generation Sequencing (NGS) Solution Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Next Generation Sequencing (NGS) Solution in 2022
Figure 70. Manufacturing Process Analysis of Next Generation Sequencing (NGS) Solution
Figure 71. Next Generation Sequencing (NGS) Solution Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
